Search research articles
Contact Us
Filters
Showing results (421-430 of 491) with videos related to
Page
of 50
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver disease
Benedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
Journal of Hepatology
|
February 17, 2020
HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure
Markus Trieb, Florian Rainer, Vanessa Stadlbauer, et al.
The American Journal of Gastroenterology
|
May 13, 2021
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
Monica Pons, Salvador Augustin, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics
|
April 14, 2019
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort
Bernhard Scheiner, Martha M Kirstein, Florian Hucke, et al.
Hepatology (Baltimore, Md.)
|
May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Scientific Reports
|
June 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats
Philipp Schwabl, Ksenia Brusilovskaya, Paul Supper, et al.
JHEP Reports : Innovation in Hepatology
|
January 19, 2026
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease
Georg Kramer, Benedikt Simbrunner, Mathias Jachs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement
Marlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis
Lukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Hepatology (Baltimore, Md.)
|
March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
Georg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
Page
of 50
Search research articles
Search
Showing results (421-430 of 491) with videos related to
Sort By:
Page
of 50
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver disease
Benedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
Journal of Hepatology
|
February 17, 2020
HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure
Markus Trieb, Florian Rainer, Vanessa Stadlbauer, et al.
The American Journal of Gastroenterology
|
May 13, 2021
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
Monica Pons, Salvador Augustin, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics
|
April 14, 2019
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort
Bernhard Scheiner, Martha M Kirstein, Florian Hucke, et al.
Hepatology (Baltimore, Md.)
|
May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Scientific Reports
|
June 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats
Philipp Schwabl, Ksenia Brusilovskaya, Paul Supper, et al.
JHEP Reports : Innovation in Hepatology
|
January 19, 2026
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease
Georg Kramer, Benedikt Simbrunner, Mathias Jachs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement
Marlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis
Lukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Hepatology (Baltimore, Md.)
|
March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
Georg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
Page
of 50